Delivery Order SPE2DR25D1109-SPE2DR26FFF3L
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,119.39 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen/ml, a pharmaceutical product for medical supply needs. This firm fixed-price delivery order, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a $1,729.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of July 23, 2025. This is a non-set-aside, competitively awarded contract for pharmaceutical supply, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the pharmaceutical product Emgality 120 mg/mL pen on May 20, 2025, with a ceiling value of $1,037.40. This firm fixed-price contract is non-competitive and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.40 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen delivery. This competitively awarded, firm fixed-price delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $8,299.20 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pens on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-competitive, firm fixed-price delivery order represents a small-value pharmaceutical procurement fulfilling federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the...
- The Defense Logistics Agency awarded a delivery order valued at $1,401.40 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen (injectable migraine treatment) with a completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contract specifies performance at the company's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,990.63 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the...
- The Defense Logistics Agency awarded a $1,729.00 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement fulfilling...
- The Defense Logistics Agency awarded a delivery order valued at $5,187.45 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen medication on September 24, 2025, with completion scheduled for September 25, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026. The award was made on a firm fixed price basis...
- The Defense Logistics Agency awarded a $1,296.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with a completion date of September 25, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFF3LDelivery Order
The Defense Logistics Agency awarded a $2,008.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen medication, with an ultimate completion date of October 21, 2025. This non-set-aside, competitively awarded contract represents a pediatric delivery supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to military healthcare programs worldwide. Through this flexible contract mechanism, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning itself as a critical vendor within the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/20/25 |